✦ LIBER ✦

Intraperitoneal (ip) Cisplatin-Mitoxantrone-Interferon-α2b in Ovarian Cancer Patients with Minimal Residual Disease

✍ Scribed by G. Frasci; A. Tortoriello; G. Facchini; S. Conforti; A. Cardone; G. Persico; P. Mastrantonio; R.V. Iaffioli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intraperitoneal Carboplatin with or with

✍ M. Bruzzone; A. Rubagotti; A. Gadducci; E. Catsafados; G. Foglia; I. Brunetti; P 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 97 KB

385 - Intraperitoneal (IP) interferon A2

✍ P. Kosmidis; D. Bafaloukos; D. Skarlos; N. Pavlidis; G. Aravantinos; A. Athanasi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 389 KB

Characteristics of patients with small-v

✍ Maurie Markman; Jonathan S. Berek; John A. Blessing; William P. McGuire; Jeffrey 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 675 KB

Single-dose intraperitoneal radioimmunot

✍ F. Crippa; G. Bolis; E. Seregni; N. Gavoni; G. Scarfone; C. Ferraris; G.L. Burag 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 621 KB

Intraperitoneal Mitoxantrone or Floxurid

✍ Franco M. Muggia; P.Y. Liu; David S. Alberts; Darryl L. Wallace; Robert V. O'Too 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Successful treatment with interferon-α-2

✍ Ichikawa, N; Shimizu, I; Yotsumoto, M; Ueno, M; Sumi, M; Kobayashi, H 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB